• home
• contacts

Scientific Programme

THURSDAY 19 NOVEMBER

10.15-10.40 Opening Ceremony:

• Introduction by A. Bosi (Florence) & D. Niederwieser (Leipzig)
• 10.40-11.00 R. Saccardi (Florence): HSCT for autoimmune diseases from the lab to the bedside

11.00-13.00 Plenary Session 1
General Overview and Immunological Mechanisms:

Chairs : M. Pasquini (Milwaukee), D. Niederwieser (Leipzig)
• 1. S. Romagnani (Florence): Mechanisms of immunologic tolerance
• 2. A Radbruch (Berlin): Role of immunological memory in ADs
• 3. P. Muraro (London): Restoring the self tolerance, lessons from the clinic
• 4. J. Snowden (Sheffield) Choice of conditioning regimens: 12 years of experience
• 5. R. Nash (Seattle): Role of allogeneic HSCT

Lunch 13.00-14.00

14.00-15.30 Oral Session:
Disease-specific clinical experience - Multiple Sclerosis and Systemic Sclerosis

Chairs : A. Fassas (Thessaloniki ), L. Griffith (Bethesda)
• 1. G.L. Mancardi (Genoa): European activity in MS
• 2. H. Atkins (Ottawa): American activity in MS
• 3. D. Farge (Paris): European activity in SSc
• 4. M. Mayes (Houston): American activity in SSc

Break 15.30-15.45

15.45-17.15 Oral Session:
Disease-specific clinical experience - Systemic Lupus Erythematosus, Crohn’s and Cytopenias

Chairs : S. Pavletic (Bethesda), A. Bosi (Florence)

• 1. D. Jayne (Cambridge): European SLE database analysis
• 2. G. Illei (Bethesda): Autologous transplantation for SLE – NIH trial experience
• 3. M. Allez (Paris): HSCT for Crohn’s disease
• 4. M. Rabusin (Trieste): Paediatric experiences
• 5. J. Passweg (Geneva): Autoimmune Cytopenias

17.30-19 Poster viewing

FRIDAY 20 NOVEMBER

08.30-10.30 Panel Discussions:
- Ongoing trials and Future developments

• Multiple Sclerosis: Panel coordinators G.L. Mancardi (Genoa), M. Freedman (Ottawa)
• Systemic Sclerosis: Panel coordinators J. Van Laar (Newcastle), C. Denton (London)
• Systemic Lupus Erythematosus: Panel coordinators D. Farge (Paris), R. Cervera (Barcelona)
• Crohn’s Disease: Panel coordinators M. Allez (Paris), S. Ardizzone (Milan)
• Cytopenias: Panel coordinators J. Passweg (Geneva), A. Bacigalupo (Genova)

10.30-11.00 Coffee Break

11.00-12.30 Panel Discussion Results

Chairs : R. Arnold (Berlin), R. Saccardi (Florence)

• Multiple Sclerosis: M. Freedman (Ottawa)
• Systemic Sclerosis: J. Van Laar (Newcastle)
• Systemic Lupus Erythematosus: M. Cervera (Barcelona)
• Crohn’s Disease: Panel coordinator M. Allez (Paris)
• Cytopenias: Panel coordinator J. Passweg (Geneva)
• 12.15-12.30 Final Remarks: A Marmont (Genova)

12.30-13.30 Lunch

Lunch Symposium: 13.00-13.30 HSCT for ADs:

13.30-14.30: Selected Oral Abstracts

14.30 – 16.15 Plenary session II:
Emerging directions in HSCT for Autoimmune Diseases

Chairs : F. Lanza (Ferrara), A. Bacigalupo (Genova)
• 1. J. Voltarelli (Ribeirão Preto, Brazil): HSCT in Type 1 diabetes: Update of the Brazilian prospective trial
• 2. A Tyndall (Basel): EULAR and stem cell transplantation of autoimmune diseases
• 3. K. Sullivan (Durham): Clinical trials for ADs: fund raising and biobanking
• 4. F. Hiepe (Berlin): New therapeutic strategies in SLE
• 5. D. Kerr (Baltimore): High dose chemotherapy without HSCT: pros and cons
• 6. R. Burt (Chicago): Reduced intensity conditioning regimens in MS
• 7. R. Martin (Hamburg): Gene profiling and patient selection in MS

16.15-16.30 Conclusions - Closing Comments

• welcome address
• important information
• scientific programme
• registration
• call for abstracts
• hotel accommodation
• speakers & authors
• sponsorship & exhibitors
• general information